:
| Printer FriendlyClick to print this page | Add to Favorites Click to add to favorites| Font Size 

DOD Medical Materiel Quality Control Messages (MMQC)/Medical Materiel Information Messages (MMI) & Images

Army Seal Air Force Seal Navy Seal Marine Corp Seal DOD Seal
MMQC-14-1407

Medical Material Quality Control Message

MMQC-14-1407


Message Number: MMQC-14-1407
Released On: 06-MAY-14
Message Class: Informational
Material Type: Vaccine
MMQC\MMI Reference:
FDA Recall Reference:
ECRI Reference:
DLA Reference:
MFG Release Date:

Subject:

Japanese Encephalitis Vaccine (IXIARO) / Update



Reason / Information:

Japanese encephalitis vaccine (IXIARO) was licensed for use in children two months and older in 2013. Vaccine dosing for children age 2 - 35 months is 0.25 ml. Dosing for children and adults age 36 months and older is 0.5 ml. The presentation for both the pediatric and adult vaccine is a 0.5 ml pre-filled syringe with a red line mark on the syringe barrel indicating the 0.25ml dose. (See attachment A) (See Image on Message under Additional Documentation/Attachment).

The National Drug Control (NDC) number for both types of syringe is the same. If vaccinating children younger than 36 months, place a �2G� advice code when ordering to receive the red-lined syringes. All syringe packages approved for use in children younger than 36 months clearly indicate �children 2 months to less than 3 years of age: 0.25ml dose� on the front of the box. (See Attachment B) (See Image on Message under Additional Documentation/Attachment).

Note: DO NOT use the unmarked syringe for children age 2 months to 35 months. DO NOT attempt to manipulate or withdraw 0.25 ml from the unmarked 0.5 ml syringes. Syringes without the red line may be used for administering vaccine to patients over the age of 36 months. Defer vaccination of children 35 months and younger until receipt of the correctly marked syringes.


Disposition / Instructions:

Continue to order/use the unmarked syringes, with an expiration date of DEC 2014 for patients that are 36 months of age or older until the supply is depleted.

Recommend separating and clearly labeling product if clinic must carry both presentations.

For general questions regarding this message call 703-681-5558 or 877-438-8222.


Service/Additional Instructions:


POC Contact Information:

US AIR FORCE:
Email: afmoa.sgalc@us.af.mil
Phone (COMM): 301-619-4170
Phone (DSN): 343-4170
Fax: 301-619-2557

US ARMY:
Email: usarmy.detrick.medcom-usamma.mbx.doc@mail.mil
Phone (COMM): 301-619-4300
Phone (DSN): 343-4300
Fax: 301-619-4468

US NAVY:
Email: MMQC2@MED.NAVY.MIL
Phone (COMM): 301-619-3085
Phone (DSN): 343-3085
Fax: 301-619-2473

USAMMC-E:
Email: usarmy.rheinland-pfalz.medcom-usammce.list.dtd-quality-assurance@mail.mil
Phone (COMM): 011-49-6331-86-7118/7181
Phone (DSN): 495-7118
Fax: 6218


Additional Message Recipients:

Please ensure dissemination of this information to the following:

Command Channels
Immunization Clinics
Medical Log Officers
Medical Staff
Pharmacy Officers
Supply Officers
Supported Activities/Centers


Message Dissemination Authorization

AF Activities Will Take Action As Prescribed In Afi 41-209, Medical Logistics Support, Chapters 3 And 9. For Majcoms & Ngb--This Msg Has Been Transmitted To All Designated Subordinate Medical Activities.

See Army Regulation (Ar) 40-61, 28 January 2005, Chapter 4, And The Department Of The Army Supply Bulletin (Sb 8-75-11) For Applicable Policies And Procedures.

DODD 5105.22 and DODD 6025.13


Additional Documentation / Attachments

MMQC-14-1407_1.pdf


*** END OF MESSAGE ***
Last Modified Date: 08/01/2014